Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, et al. N Engl J Med 2020 Dec 1. doi: 10.1056/NEJMc2031670.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, et al. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. N Engl J Med 2020 Dec 1. doi: 10.1056/NEJMc2031670.
PMID: 33259154